Paid Clinical Trials Atlanta

Discover 1,558 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,558

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Atlanta GA, Decatur GA, Chamblee GA, Columbus GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Danvatirsen & PembrolizumabActivity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Recruiting

PHASE2

Sponsor:

Flamingo Therapeutics NV

Location:

Atlanta GA, Greenville SC, Cincinnati OH, Baton Rouge LAshow 16 more

Code:

NCT05814666

Conditions

HNSCC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Danvatirsen

Pembrolizumab

Rexlemestrocel-L & HAEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

Recruiting

PHASE3

Sponsor:

Mesoblast, Ltd.

Location:

Dunwoody GA, Birmingham AL, Hendersonville NC, Jacksonville FLshow 18 more

Code:

NCT06325566

Conditions

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rexlemestrocel-L + HA mixture

Saline

ECTElectroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Recruiting

Sponsor:

Brent Forester

Location:

Atlanta GA, Grand Rapids MI, Glen Oaks NY, Rochester MNshow 1 more

Code:

NCT03926520

Conditions

Alzheimer Dementia

Agitation,Psychomotor

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Electroconvulsive Therapy (ECT)

NKX019NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)

Recruiting

PHASE1

Sponsor:

Nkarta, Inc.

Location:

Atlanta GA, Gainesville FL, Little Rock AR, New York NYshow 1 more

Code:

NCT06557265

Conditions

Lupus Nephritis

Glomerulonephritis

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NKX019

Cyclophosphamide

Interleukin-2 & PembrolizumabLow-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Recruiting

EARLY_PHASE1

Sponsor:

Emory University

Location:

Atlanta GA

Code:

NCT05493566

Conditions

Lung Non-Small Cell Carcinoma

Stage IV Lung Cancer AJCC V8

Stage IVA Lung Cancer AJCC V8

Stage IVB Lung Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Aldesleukin

Pembrolizumab

GSK4172239DA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Recruiting

PHASE1

Sponsor:

GlaxoSmithKline

Location:

Atlanta GA, Riverdale GA, Columbus GA, Raleigh NCshow 3 more

Code:

NCT05660265

Conditions

Hematologic Diseases

Anaemia, Sickle Cell

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

GSK4172239D

Placebo

Thrombin Receptor AntagonistExcellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Atlanta GA, Dallas TX, Oklahoma City OK, Manhasset NYshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

TTVRTTVR Early Feasibility Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Atlanta GA, Birmingham AL, Cincinnati OH, Columbus OHshow 15 more

Code:

NCT04433065

Conditions

Tricuspid Regurgitation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Intrepid™ TTVR System

AnticoagulationAnticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting

PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Atlanta GA, Durham NC, Raleigh NC, Greenville NCshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

LurbinectedinStudy of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Recruiting

PHASE1

PHASE2

Sponsor:

Jazz Pharmaceuticals

Location:

Atlanta GA, Memphis TN, Cincinnati OH, Saint Petersburg FLshow 11 more

Code:

NCT05734066

Conditions

Refractory Ewing Sarcoma

Relapsed Ewing Sarcoma

Ewing Sarcoma

Eligibility Criteria

Sex: All

Age: 2 - 30

Healthy Volunteers: Not accepted

Interventions

Lurbinectedin